Bruker Corporation
BRKR
$75.07
-$0.75-0.99%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.31% | 19.82% | 16.26% | 15.89% | 15.45% |
| Total Other Revenue | -- | 111.29% | -- | -- | 92.86% |
| Total Revenue | 5.31% | 20.62% | 16.26% | 15.89% | 15.18% |
| Cost of Revenue | 11.34% | 22.59% | 18.18% | 18.00% | 12.79% |
| Gross Profit | -0.14% | 18.79% | 14.53% | 13.86% | 17.42% |
| SG&A Expenses | 19.78% | 25.70% | 18.21% | 13.00% | 11.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 57.14% | 300.00% | 162.75% | 123.81% | 0.00% |
| Total Operating Expenses | 14.86% | 25.29% | 20.98% | 17.74% | 13.40% |
| Operating Income | -37.03% | 0.96% | -1.65% | 5.02% | 23.75% |
| Income Before Tax | -33.08% | 98.60% | -7.79% | 11.64% | 14.15% |
| Income Tax Expenses | -33.78% | 58.55% | -25.24% | 0.00% | -6.27% |
| Earnings from Continuing Operations | -32.82% | 108.14% | 0.34% | 16.30% | 24.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -22.22% | 200.00% | -100.00% | -250.00% | -80.00% |
| Net Income | -33.46% | 110.99% | 0.00% | 15.35% | 24.19% |
| EBIT | -37.03% | 0.96% | -1.65% | 5.02% | 23.75% |
| EBITDA | -24.54% | 8.79% | 2.21% | 8.02% | 22.33% |
| EPS Basic | -32.72% | 113.32% | 0.82% | 17.10% | 27.22% |
| Normalized Basic EPS | -26.67% | 16.43% | -4.00% | 14.32% | 20.44% |
| EPS Diluted | -32.69% | 112.72% | 1.69% | 17.88% | 26.95% |
| Normalized Diluted EPS | -26.61% | 16.66% | -3.95% | 14.26% | 20.57% |
| Average Basic Shares Outstanding | -1.09% | -1.09% | -0.81% | -1.48% | -2.39% |
| Average Diluted Shares Outstanding | -1.15% | -1.28% | -0.87% | -1.40% | -2.51% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.48% | -0.53% | 0.00% | -0.16% | -0.21% |
